1.Application of Image Segment Method Based on GVF Snake Model for RA
Tao SUN ; Jiawang WANG ; Shanqing HAN
Chinese Journal of Medical Physics 2009;26(6):1504-1507
Objective: To investigate the potential of gradient vector flow(GVF) Snake model as a method of image segment in radiographic absorptiometry method (RA) which is used to qualify bone mineral density. Methods: The Gradient Vector Flow model and the Region Growing method were applied in the segmentation of the middle phalanges image and aluminum wedge image separately in this paper. Then, the results can be compared. Results: The experiments shows that GVF Snake model is not only robust and practicable, but also segmentation results are in line with the actual border. Conclusions: GVF Snake model is very useful, and can be widely used in qualifying bone mineral density.
2.Imaging Theory、Predominance and Clinical Applications of PET/CT
Tao SUN ; Shanqing HAN ; Jiawang WANG
Chinese Journal of Medical Physics 2010;27(1):1581-1582,1587
Objective:To explore the imaging theory、Predominance and clinical applications of PET/CT.Methods:The definition of PET/CT was firstly explained in the paper.Then,we could learn not only the imaging theory and important parameters,but also predominance and clinical applications of PET/CT.Results:PET/CT can make the modality of PET and CT images,so that it is more widely used.Conclusion:PET/CT represents the highest level of medical imaging equipment nowadays,It is the ideal combination of the medical imaging diagnostic echnology.
3.Deficiency of ASGR1 Alleviates Diet-Induced Systemic Insulin Resistance via Improved Hepatic Insulin Sensitivity
Xiaorui YU ; Jiawang TAO ; Yuhang WU ; Yan CHEN ; Penghui LI ; Fan YANG ; Miaoxiu TANG ; Abdul SAMMAD ; Yu TAO ; Yingying XU ; Yin-Xiong LI
Diabetes & Metabolism Journal 2024;48(4):802-815
Background:
Insulin resistance (IR) is the key pathological basis of many metabolic disorders. Lack of asialoglycoprotein receptor 1 (ASGR1) decreased the serum lipid levels and reduced the risk of coronary artery disease. However, whether ASGR1 also participates in the regulatory network of insulin sensitivity and glucose metabolism remains unknown.
Methods:
The constructed ASGR1 knockout mice and ASGR1-/- HepG2 cell lines were used to establish the animal model of metabolic syndrome and the IR cell model by high-fat diet (HFD) or drug induction, respectively. Then we evaluated the glucose metabolism and insulin signaling in vivo and in vitro.
Results:
ASGR1 deficiency ameliorated systemic IR in mice fed with HFD, evidenced by improved insulin intolerance, serum insulin, and homeostasis model assessment of IR index, mainly contributed from increased insulin signaling in the liver, but not in muscle or adipose tissues. Meanwhile, the insulin signal transduction was significantly enhanced in ASGR1-/- HepG2 cells. By transcriptome analyses and comparison, those differentially expressed genes between ASGR1 null and wild type were enriched in the insulin signal pathway, particularly in phosphoinositide 3-kinase-AKT signaling. Notably, ASGR1 deficiency significantly reduced hepatic gluconeogenesis and glycogenolysis.
Conclusion
The ASGR1 deficiency was consequentially linked with improved hepatic insulin sensitivity under metabolic stress, hepatic IR was the core factor of systemic IR, and overcoming hepatic IR significantly relieved the systemic IR. It suggests that ASGR1 is a potential intervention target for improving systemic IR in metabolic disorders.
4.Deficiency of ASGR1 Alleviates Diet-Induced Systemic Insulin Resistance via Improved Hepatic Insulin Sensitivity
Xiaorui YU ; Jiawang TAO ; Yuhang WU ; Yan CHEN ; Penghui LI ; Fan YANG ; Miaoxiu TANG ; Abdul SAMMAD ; Yu TAO ; Yingying XU ; Yin-Xiong LI
Diabetes & Metabolism Journal 2024;48(4):802-815
Background:
Insulin resistance (IR) is the key pathological basis of many metabolic disorders. Lack of asialoglycoprotein receptor 1 (ASGR1) decreased the serum lipid levels and reduced the risk of coronary artery disease. However, whether ASGR1 also participates in the regulatory network of insulin sensitivity and glucose metabolism remains unknown.
Methods:
The constructed ASGR1 knockout mice and ASGR1-/- HepG2 cell lines were used to establish the animal model of metabolic syndrome and the IR cell model by high-fat diet (HFD) or drug induction, respectively. Then we evaluated the glucose metabolism and insulin signaling in vivo and in vitro.
Results:
ASGR1 deficiency ameliorated systemic IR in mice fed with HFD, evidenced by improved insulin intolerance, serum insulin, and homeostasis model assessment of IR index, mainly contributed from increased insulin signaling in the liver, but not in muscle or adipose tissues. Meanwhile, the insulin signal transduction was significantly enhanced in ASGR1-/- HepG2 cells. By transcriptome analyses and comparison, those differentially expressed genes between ASGR1 null and wild type were enriched in the insulin signal pathway, particularly in phosphoinositide 3-kinase-AKT signaling. Notably, ASGR1 deficiency significantly reduced hepatic gluconeogenesis and glycogenolysis.
Conclusion
The ASGR1 deficiency was consequentially linked with improved hepatic insulin sensitivity under metabolic stress, hepatic IR was the core factor of systemic IR, and overcoming hepatic IR significantly relieved the systemic IR. It suggests that ASGR1 is a potential intervention target for improving systemic IR in metabolic disorders.
5.Deficiency of ASGR1 Alleviates Diet-Induced Systemic Insulin Resistance via Improved Hepatic Insulin Sensitivity
Xiaorui YU ; Jiawang TAO ; Yuhang WU ; Yan CHEN ; Penghui LI ; Fan YANG ; Miaoxiu TANG ; Abdul SAMMAD ; Yu TAO ; Yingying XU ; Yin-Xiong LI
Diabetes & Metabolism Journal 2024;48(4):802-815
Background:
Insulin resistance (IR) is the key pathological basis of many metabolic disorders. Lack of asialoglycoprotein receptor 1 (ASGR1) decreased the serum lipid levels and reduced the risk of coronary artery disease. However, whether ASGR1 also participates in the regulatory network of insulin sensitivity and glucose metabolism remains unknown.
Methods:
The constructed ASGR1 knockout mice and ASGR1-/- HepG2 cell lines were used to establish the animal model of metabolic syndrome and the IR cell model by high-fat diet (HFD) or drug induction, respectively. Then we evaluated the glucose metabolism and insulin signaling in vivo and in vitro.
Results:
ASGR1 deficiency ameliorated systemic IR in mice fed with HFD, evidenced by improved insulin intolerance, serum insulin, and homeostasis model assessment of IR index, mainly contributed from increased insulin signaling in the liver, but not in muscle or adipose tissues. Meanwhile, the insulin signal transduction was significantly enhanced in ASGR1-/- HepG2 cells. By transcriptome analyses and comparison, those differentially expressed genes between ASGR1 null and wild type were enriched in the insulin signal pathway, particularly in phosphoinositide 3-kinase-AKT signaling. Notably, ASGR1 deficiency significantly reduced hepatic gluconeogenesis and glycogenolysis.
Conclusion
The ASGR1 deficiency was consequentially linked with improved hepatic insulin sensitivity under metabolic stress, hepatic IR was the core factor of systemic IR, and overcoming hepatic IR significantly relieved the systemic IR. It suggests that ASGR1 is a potential intervention target for improving systemic IR in metabolic disorders.